| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6192780 | Journal of Thoracic Oncology | 2015 | 10 Pages |
Abstract
High CD10+/low CD20+ immune cell infiltration ratio is a significant prognostic factor of lung squamous cell carcinoma. Immunomodulatory therapy of tumor-specific neutrophil and B-lymphocyte responses may have applicability in the treatment of lung squamous cell carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kyuichi MD, PhD, Jun-ichi MD, PhD, Hideki MD, Daniel H. MD, Kaitlin M. MS, Camelia S. MD, MS, William D. MD, David R. MD, FACS, Prasad S. MD, FACS, FCCP,